Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Calcification: Features

Editor's Corner
Caught Between a Rock and a Hard Place
03/24/2022
Dr. Walker comments on the article "Shockwave IVL as the Last Option to Restore Flow in a Nonagenarian With an ACS."
Dr. Walker comments on the article "Shockwave IVL as the Last Option to Restore Flow in a Nonagenarian With an ACS."
Dr. Walker comments on the...
03/24/2022
Vascular Disease Management
Video
Caught Between a Rock and a Hard Place
03/24/2022
Dr. Walker comments on the article by Dr. Radaideh and colleagues, "Shockwave Intravascular Lithoplasty as the Last Option to Restore Flow in a Nonagenarian With an Acute Coronary Syndrome."
Dr. Walker comments on the article by Dr. Radaideh and colleagues, "Shockwave Intravascular Lithoplasty as the Last Option to Restore Flow in a Nonagenarian With an Acute Coronary Syndrome."
Dr. Walker comments on the...
03/24/2022
Vascular Disease Management
Case Report
Shockwave Intravascular Lithoplasty as the Last Option to Restore Flow in a Nonagenarian With an Acute Coronary Syndrome
03/24/2022
The effectiveness of coronary lithotripsy as a bailout approach.
The effectiveness of coronary lithotripsy as a bailout approach.
The effectiveness of coronary...
03/24/2022
Vascular Disease Management
Dr. Marianne Brodmann
Video
RANGER II SFA Randomized Trial: Results in Women, Patients With Occlusions, and Severe Calcifications
02/22/2022
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022. 
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022. 
Dr. Marianne Brodmann discusses...
02/22/2022
Vascular Disease Management
Fellows' Corner
Endovascular Limb Salvage Therapy of Densely Calcified Femoropopliteal Disease Using Excimer Laser Atherectomy
12/03/2021
Critical limb threatening ischemia is the manifestation of advanced lower extremity peripheral arterial disease, typically afflicting patients with underlying significant comorbidities.
Critical limb threatening ischemia is the manifestation of advanced lower extremity peripheral arterial disease, typically afflicting patients with underlying significant comorbidities.
Critical limb threatening...
12/03/2021
Vascular Disease Management
Scott REALITY
AMP 2021
Scott: 12-Month Results of the REALITY Study of Directional Atherectomy Alone and With Drug-Coated Balloons
08/13/2021
In a session devoted to atherectomy and its use in patients with critical limb ischemia (CLI), Eric C. Scott, MD (The Iowa Clinic, Des Moines, Iowa), shared the 12-month results of the REALITY study of directional atherectomy alone and with...
In a session devoted to atherectomy and its use in patients with critical limb ischemia (CLI), Eric C. Scott, MD (The Iowa Clinic, Des Moines, Iowa), shared the 12-month results of the REALITY study of directional atherectomy alone and with...
In a session devoted to...
08/13/2021
Vascular Disease Management
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
Original Research
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
08/01/2021
The purpose of this study is to determine the prevalence of unsuspected hemodynamically significant coronary stenosis in CLI patients and to assess the potential benefit of FFRct analysis in patient management.
The purpose of this study is to determine the prevalence of unsuspected hemodynamically significant coronary stenosis in CLI patients and to assess the potential benefit of FFRct analysis in patient management.
The purpose of this study is to...
08/01/2021
Vascular Disease Management
Interview
DISRUPT PAD III Trial Summary
07/19/2021
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and...
07/19/2021
Vascular Disease Management
Original Contribution
A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy
06/11/2021
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this...
06/11/2021
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement